about
Herbal hepatotoxicity: challenges and pitfalls of causality assessment methodsEvaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicityCausality assessment in hepatotoxicity by drugs and dietary supplementsKey Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation PlansAn automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.Hepatic safety of antibiotics used in primary careHerbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging stepsHerbalife hepatotoxicity: Evaluation of cases with positive reexposure testsAssessment of drug-induced liver injury in clinical practice.Drug-induced liver injury: insights from genetic studies.Rechallenge in drug-induced liver injury: the attractive hazard.Predictive genetic testing for drug-induced liver injury: considerations of clinical utility.Clinical and causality assessment in herbal hepatotoxicity.Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.Acute Liver Failure after Initiation of Rivaroxaban: A Case Report and Review of the Literature.Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: clinical and in vitro evidence.Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists.Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality.Drug-induced cholestatic hepatitis: how late can it occur even after the cessation of the culpable drug?Idiosyncratic drug hepatotoxicity: a 2008 update.Atomoxetine-induced hepatitis in a child.
P2860
Q26824747-0611593D-687E-4A8C-B6A6-9932314FDF8AQ27027301-5C01CCB3-0E8E-4D23-A40B-469E25859C42Q27488354-1C51E22C-E28A-4535-B1F9-9E922AA9EC62Q28075991-67ED84ED-9F1A-4B33-AA20-9EF8A012DDF9Q30830530-05E3FAE8-97BF-416B-802B-CAD8E23BF4AEQ35037383-80757AB6-7FB0-4E35-81AC-1A3014CD047CQ35531281-8CFFAE3E-6FBE-46B4-A0C4-2681F108EF47Q37049109-3783E8EE-F1C0-4631-9D34-32489CC20933Q37114105-1ABD5C0C-0916-4B9E-BCE4-14830FB8AF92Q37598897-5E2D830D-2015-47D2-A3C0-5DCD385870CDQ37646772-1102DA4C-ED5E-4B8A-A318-6972579A6D9BQ38031096-1F99E8D1-ADE7-4A8B-A374-40DF778C920BQ38086300-FF05476F-B792-4D73-8ADE-65FFC14C896CQ38423805-DF3E1828-85EE-4640-B1DD-6B40205C1134Q38647192-2B4696E3-09BF-418F-A7BA-AC29BD3198BAQ39389259-99E9BDE4-041F-4683-AF46-3E08A91ACAE0Q42704420-F6CF4890-882A-4F67-A571-D650C6A25583Q42963305-54DD7622-84A1-4FF5-862B-6B5BF061C962Q43202551-48F46A91-A38E-47A6-B657-E535621ED1C1Q51712894-B5B0351E-5C62-4F6E-A49A-739568F24A88Q51761833-F732941D-8647-4806-A51D-DCA7A4D76F5B
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Causality assessment in drug-induced hepatotoxicity.
@ast
Causality assessment in drug-induced hepatotoxicity.
@en
type
label
Causality assessment in drug-induced hepatotoxicity.
@ast
Causality assessment in drug-induced hepatotoxicity.
@en
prefLabel
Causality assessment in drug-induced hepatotoxicity.
@ast
Causality assessment in drug-induced hepatotoxicity.
@en
P2093
P2860
P356
P1476
Causality assessment in drug-induced hepatotoxicity
@en
P2093
M Isabel Lucena
Raquel Camargo
Rocío González-Grande
P2860
P304
P356
10.1517/14740338.3.4.329
P407
P577
2004-07-01T00:00:00Z